Search - tctmd.com

Displaying 41 - 60 of 331

Sort: Relevancy | Date

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Featured Fellow

Aditya Mehta, MBBS

Yael L. Maxwell

April 10, 2025

News Conference News ACC 2025

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

Michael O'Riordan

April 08, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Gene Therapy for HCM: Is a Cure Coming?

Presenter: Nosheen Reza

February 11, 2025

Presentation THT 2025

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Presenter: Anjali Owens

February 11, 2025

Presentation THT 2025

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Presenter: Martin Maron

February 11, 2025

Presentation THT 2025

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Presenter: Hiroo Takayama

February 11, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Case-in-the-Box: SESAME

Presenter: Adam Greenbaum

February 11, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2024

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

Presenter: Stanislav Fanta

October 27, 2024

Presentation TCT 2024

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

Presenter: Himaja Dutt Chigurupati

October 27, 2024

Presentation TCT 2024

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Kylie Duckworth

October 27, 2024

Presentation TCT 2024

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

Presenter: Nikhil Rao

October 27, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

Advertisement

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

Aditya Mehta, MBBS

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

What’s Going to Be Hot at ACC 2025?

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Gene Therapy for HCM: Is a Cure Coming?

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Will Novel Catheter Based Approaches Save the Day?

Case-in-the-Box: SESAME

Top Heart Failure News of 2024

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content